{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-005271","form_type":"8-K","ticker":"IPSC","cik":"0001850119","company_name":"Century Therapeutics, Inc.","filed_at":"2024-01-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.007181+00:00","generated_at":"2026-06-06T21:27:15.248852+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Century Therapeutics CFO Michael Diem resigns; Douglas Carr named interim CFO","bullets":["CFO Michael C. Diem resigned effective Feb 2, 2024; company has initiated a search for a permanent replacement.","Douglas Carr, SVP Finance and Operations, will serve as interim principal financial officer following Dr. Diem's departure.","Dr. Diem's resignation is not due to any disagreement with the company's operations, policies, or practices."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-005271","json":"https://secwatch.observer/filing/0001104659-24-005271.json","markdown":"https://secwatch.observer/filing/0001104659-24-005271.md","text":"https://secwatch.observer/filing/0001104659-24-005271.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850119/000110465924005271/0001104659-24-005271-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850119/000110465924005271/tm243558d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T21:27:15.248852+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4d184da3a8","claim":"Douglas Carr was appointed as interim Principal Financial Officer at Century Therapeutics, Inc..","evidence_excerpt":"Following the effectiveness of Dr. Diem’s resignation and until a new Chief Financial Officer is appointed, Douglas Carr, the Company’s Senior Vice President, Finance and Operations, will serve as interim Principal Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1850119/000110465924005271/0001104659-24-005271-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"interim Principal Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"8dffe6f684","claim":"Michael C. Diem resigned as Chief Financial Officer at Century Therapeutics, Inc..","evidence_excerpt":"On January 15, 2024, Michael C. Diem, M.D. notified Century Therapeutics, Inc. (the “Company”) of his decision to resign as Chief Financial Officer of the Company, effective as of February 2, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1850119/000110465924005271/0001104659-24-005271-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}